Treatments in Endocrinology

, Volume 5, Issue 1, pp 53–58 | Cite as

The Implantable Gastric Stimulator for Obesity

An Update of the European Experience in the LOSS (Laparoscopic Obesity Stimulation Survey) Study
Original Research Article


Objective: To evaluate the efficacy of a gastric stimulation procedure for the treatment of morbid obesity.

Methods: All implantable gastric stimulator systems were implanted in a laparoscopic procedure. We focused on the results of the LOSS (Laparoscopic Obesity Stimulation Survey) study, which was a multicenter European survey of 16 hospitals. To date, 91 patients have undergone implantable gastric stimulator implantation in the LOSS study.

Results: The patient population was comprised of 62 (68%) women and 29 (32%) men. The mean age was 41 years, mean weight was 116kg, and mean body mass index was 41 kg/m2. All surgical procedures were successfully completed. There were no deaths, and no severe peri- or postoperative complications. The mean excess weight loss (EWL) was 20% at 12 months after surgery and about 25% at 2 years after implantation. Baroscreen-selected patients achieved a 31.4% EWL, which was significantly different to the EWL of those patients who were not selected by this screening (15% EWL) [p < 0.01].

Conclusion: Gastric pacing is a promising, minimally invasive, safe, and effective surgical method that results in very little impairment of the patient. Patient selection for gastric stimulation therapy seems to be an important determinant of treatment outcome.


  1. 1.
    Cigaina V, Saggioro A, Rigo V, et al. Long-term effects of gastric pacing to reduce feed intake in swine. Obes Surg 1996; 6: 250–3PubMedCrossRefGoogle Scholar
  2. 2.
    Cigaina V, Pinato GP, Rigo V, et al. Gastric peristalsis control by mono situ electrical stimulation: a preliminary study. Obes Surg 1996; 6: 247–9PubMedCrossRefGoogle Scholar
  3. 3.
    Cigaina V. Long-term follow-up of gastric stimulation for obesity: the Mestre 8-year experience. Obes Surg 2004; 14 Suppl. 1: 14S–22SCrossRefGoogle Scholar
  4. 4.
    De Luca M, Segato G, Busetto L, et al. Progress in implantable gastric stimulation: summary of results of the European multi-center study. Obes Surg 2004; 14 Suppl. 1: S33–9Google Scholar
  5. 5.
    Miller K. Implantable electrical gastric stimulation to treat morbid obesity in the human: operative technique. Obes Surg 2002; 12 Suppl. 1: 17S–20SCrossRefGoogle Scholar
  6. 6.
    Callegari A, Michelini I, Sguazzin C, et al. Efficacy of the SF-36 questionnaire in identifying obese patients with psychological discomfort. Obes Surg 2005; 15(2): 254–60PubMedCrossRefGoogle Scholar
  7. 7.
    Miller K, Holler E, Hell E. Intragastric stimulation (IGS) for treatment of morbid obesity. Zentralbl Chir 2002; 127(12): 1049–54PubMedCrossRefGoogle Scholar
  8. 8.
    Favretti F, De Luca M, Segato G, et al. Treatment of morbid obesity with the transcend implantable gastric stimulator (IGS): a prospective survey. Obes Surg 2004; 14(5): 666–70PubMedCrossRefGoogle Scholar
  9. 9.
    Shikora SA. ‘What are the yanks doing?’ The US experience with implantable gastric stimulation (IGS) for the treatment of obesity: update on the ongoing clinical trials. Obes Surg 2004; 14 Suppl. 1: S40–8CrossRefGoogle Scholar
  10. 10.
    Saber AA. Gastric pacing: a new modality for the treatment of morbid obesity. J Invest Surg 2004; 17(2): 57–9PubMedCrossRefGoogle Scholar
  11. 11.
    Muhlmann G, Klaus A, Kirchmayr W, et al. DaVinci robotic-assisted laparoscopic bariatric surgery: is it justified in a routine setting? Obes Surg 2003; 13(6): 848–54PubMedCrossRefGoogle Scholar
  12. 12.
    Cigaina V, Hirschberg AL. Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin. Obes Res 2003; 11(12): 1456–62PubMedCrossRefGoogle Scholar
  13. 13.
    Chen J. Mechanisms of action of the implantable gastric stimulator for obesity. Obes Surg 2004; 14 Suppl. 1: S28–32CrossRefGoogle Scholar
  14. 14.
    Zhu H, Chen JD. Implantable gastric stimulation inhibits gastric motility via sympathetic pathway in dogs. Obes Surg 2005 Jan; 15(1): 95–100PubMedCrossRefGoogle Scholar
  15. 15.
    Yao S, Ke M, Wang Z, et al. Visceral sensitivity to gastric stimulation and its correlation with alterations in gastric emptying and accommodation in humans. Obes Surg 2005 Feb; 15(2): 247–53PubMedCrossRefGoogle Scholar
  16. 16.
    Qin C, Sun Y, Chen JD, et al. Gastric electrical stimulation modulates neuronal activity in nucleus tractus solitarii in rats. Auton Neurosci 2005 Apr 29; 119(1): 1–8PubMedCrossRefGoogle Scholar
  17. 17.
    Miller K. Obesity: surgical options. Best Pract Res Clin Gastroenterol 2004; 18(6): 1147–65PubMedGoogle Scholar
  18. 18.
    Deitel M. How much weight loss is sufficient to overcome major comorbidities? Obes Surg 2001; 11:659PubMedCrossRefGoogle Scholar
  19. 19.
    Council on scientific affairs. Treatment of obesity in adults. JAMA 1988; 260: 2547–51CrossRefGoogle Scholar
  20. 20.
    Stevens J, Cai J, Pamuk ER, et al. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998; 338(1): 1–7PubMedCrossRefGoogle Scholar
  21. 21.
    Pories WJ, Swanson MS, MacDonald K, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339–52PubMedCrossRefGoogle Scholar
  22. 22.
    Pi-Sunyer FX. Weight loss and mortality in type 2 diabetes. Diabetes Care 2000; 23: 1451–2PubMedCrossRefGoogle Scholar
  23. 23.
    Lantz H, Peltonen M, Gren L, et al. A dietary and behavioural programme for the treatment of obesity: a 4-year clinical trial and a long-term post-treatment follow-up. J Intern Med 2003; 254: 272–9PubMedCrossRefGoogle Scholar
  24. 24.
    McTigue KM, Harris R, Hemphill B, et al. Screening and interventions for obesity in adults: summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2003; 139: 933–49PubMedGoogle Scholar
  25. 25.
    Kopelman PG. Obesity as a medical problem. Nature 2000; 404: 635–43PubMedGoogle Scholar
  26. 26.
    Wadden TA. Treatment of obesity by moderate and severe caloric restriction: results of clinical research trials. Ann Intern Med 1993; 119: 688–93PubMedGoogle Scholar
  27. 27.
    Andersen T, Backer OG, Stokholm KH, et al. Randomized trial of diet and gastroplasty compared with diet alone in morbid obesity. N Engl J Med 1984; 310: 352–6PubMedCrossRefGoogle Scholar
  28. 28.
    National Institute of Health. Health implications of obesity. Obes Res 1998; 6: 51–209CrossRefGoogle Scholar
  29. 29.
    National Institute of Health. Consensus statement: gastrointestinal surgery for severe obesity. Ann Intern Med 1991; 115: 956–61Google Scholar
  30. 30.
    Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004; 240: 416–24PubMedCrossRefGoogle Scholar
  31. 31.
    Hell E, Miller KA, Moorehead MK, et al. Evaluation of health status and quality of life after bariatric surgery: comparison of standard Roux-en-Y gastric bypass, vertical banded gastroplasty and laparoscopic adjustable silicone gastric banding. Obes Surg 2000; 10: 214–9PubMedCrossRefGoogle Scholar
  32. 32.
    Stunkard A, Wadden T. Psychological aspects of severe obesity. Am J Clin Nutr 1992; 55: 524–32Google Scholar
  33. 33.
    Klein S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004; 350: 2549–7PubMedCrossRefGoogle Scholar
  34. 34.
    Steinbrook R. Surgery for severe obesity. N Engl J Med 2004 Mar 11; 350: 1075–9PubMedCrossRefGoogle Scholar
  35. 35.
    Buchwald H. A bariatric surgery algorithm. Obes Surg 2002; 12: 733–46PubMedCrossRefGoogle Scholar
  36. 36.
    Gagner M, Steffen R, Biertho L, et al. Laparoscopic adjustable gastric banding and duodenal switch for morbid obesity: technique and preliminary results. Obes Surg 2003; 13: 444–9PubMedCrossRefGoogle Scholar
  37. 37.
    Kothari SN, DeMaria EJ, Sugerman HJ, et al. Lap-band failures: conversion to gastric bypass and their preliminary outcomes. Surgery 2002; 131(6): 625–9PubMedCrossRefGoogle Scholar
  38. 38.
    DeMaria EJ, Sugerman HJ, Meador JG, et al. High failure rate after laparoscopic adjustable silicone gastric banding for treatment of morbid obesity. Ann Surg 2001; 233(6): 809–18PubMedCrossRefGoogle Scholar
  39. 39.
    Manco M, Nanni G, Tondolo V, et al. Hypocalcemia complicating near-total thyroidectomy in patients with coexisting lipid malabsorption due to biliopancreatic diversion. Obes Surg 2004; 14(10): 1429–34PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2006

Authors and Affiliations

  1. 1.Krankenhaus Hallein and the Ludwig Boltzmann Institute for Gastroenterology and Experimental SurgeryHalleinAustria
  2. 2.University Hospital InnsbruckInnsbruckAustria

Personalised recommendations